I realize that everyone is suffering from Patent Reform Fatigue regarding the new rules the Patent Office wants to foist on the public but here is a quick update. Gene Quinn, at the PLI blog is reporting that the oral hearing on GlaxoSmithKline, Tafas and USPTO cross motions for Summary Judgment was today and that […]